Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00391274 · COMPLETED

Trial details

NCT number: NCT00391274
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2006-10-01
Primary completion: 2008-12-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.